These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36286483)

  • 21. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
    Cox MA; Leahy J; Hardwick JM
    J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex.
    Su MT; Liu IH; Wu CW; Chang SM; Tsai CH; Yang PW; Chuang YC; Lee CP; Chen MR
    J Virol; 2014 Aug; 88(16):8883-99. PubMed ID: 24872582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
    Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
    J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.
    Chen YJ; Tsai WH; Chen YL; Ko YC; Chou SP; Chen JY; Lin SF
    PLoS One; 2011 Mar; 6(3):e17809. PubMed ID: 21423768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
    J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.
    Tung CP; Chang FR; Wu YC; Chuang DW; Hunyadi A; Liu ST
    J Gen Virol; 2011 Aug; 92(Pt 8):1760-1768. PubMed ID: 21490247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD.
    Salamun SG; Sitz J; De La Cruz-Herrera CF; Yockteng-Melgar J; Marcon E; Greenblatt J; Fradet-Turcotte A; Frappier L
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
    Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
    J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
    Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the Epstein-Barr virus lytic cycle by moronic acid.
    Chang FR; Hsieh YC; Chang YF; Lee KH; Wu YC; Chang LK
    Antiviral Res; 2010 Mar; 85(3):490-5. PubMed ID: 19969023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.
    Heilmann AM; Calderwood MA; Johannsen E
    J Virol; 2010 Oct; 84(19):9920-31. PubMed ID: 20631124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
    Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
    Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
    Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain.
    Wang P; Day L; Lieberman PM
    J Virol; 2006 Nov; 80(22):10942-9. PubMed ID: 16971443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors.
    Chen C; Li D; Guo N
    Cancer Biol Ther; 2009 Jun; 8(11):987-95. PubMed ID: 19448399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.